Detailed price information for Applied Digital Corp (APLD-Q) from The Globe and Mail including charting and trades.

When asked today if Ireland will follow such a move, the health minister said Mounjaro, “is going through the reimbursement ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Guselkumab, whether administered every 4 or 8 weeks, demonstrates “significant inhibition” of structural damage in patients ...

DelveInsight's BAFF- and APRIL-targeted Therapies Market Size, Target Population, Competitive Landscape & Market Forecast ...

Evangeline Lilly has cancelled an appearance at the Italian Global Series Festival (IGSF) for health reasons. The star, who ...

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...

FacebookTweetPin The prospects of a ceasefire in the Middle East have dimmed after a series of comments by President Donald [ ...

Eli Lilly and Company: Lilly reports full Q4 2024 financial results and provides 2025 guidance Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound.

In Q4 2024, Eli Lilly's revenue grew 45%, driven by Mounjaro and Zepbound, the company's core weight-loss drugs. Non-incretin revenue grew by 20% compared to Q4 2023. "We exceeded our first-time ...

David Ricks; Chairman of the Board, President, Chief Executive Officer; Eli Lilly and Co Lucas Montarce; Executive Vice President and Chief Financial Officer; Eli Lilly and Co Daniel Skovronsky; Chief ...

Eli Lilly (NYSE: LLY). Q4 2024 Earnings Call. Feb 06, 2025, 10:00 a.m. ET. Read More: Earn up to $845 cash back this year ...